MX2009006889A - Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa. - Google Patents
Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa.Info
- Publication number
- MX2009006889A MX2009006889A MX2009006889A MX2009006889A MX2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- methods
- cannabinoid
- combination
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 102000012440 Acetylcholinesterase Human genes 0.000 title 1
- 108010022752 Acetylcholinesterase Proteins 0.000 title 1
- 229940022698 acetylcholinesterase Drugs 0.000 title 1
- 230000008485 antagonism Effects 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 208000011117 substance-related disease Diseases 0.000 abstract 3
- 206010013663 drug dependence Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010048650 Cholinesterase inhibition Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 201000009032 substance abuse Diseases 0.000 abstract 1
- 231100000736 substance abuse Toxicity 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000009529 traumatic brain injury Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06126584 | 2006-12-20 | ||
| PCT/EP2007/064169 WO2008074816A1 (en) | 2006-12-20 | 2007-12-19 | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006889A true MX2009006889A (es) | 2009-07-07 |
Family
ID=38024247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006889A MX2009006889A (es) | 2006-12-20 | 2007-12-19 | Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa. |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101848907A (https=) |
| AR (1) | AR064379A1 (https=) |
| BR (1) | BRPI0721060A2 (https=) |
| IN (1) | IN2009CN03566A (https=) |
| MX (1) | MX2009006889A (https=) |
| TW (1) | TW200843772A (https=) |
| ZA (1) | ZA200903779B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116033836B (zh) * | 2020-07-14 | 2024-10-18 | 利斯库生物科学有限公司 | 包含意外片球菌或来源于其的细胞外囊泡作为有效成分的用于治疗脑部疾病的组合物 |
| CN113880899B (zh) * | 2020-10-30 | 2023-06-23 | 杭州拉林智能科技有限公司 | 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用 |
-
2007
- 2007-12-17 TW TW96148210A patent/TW200843772A/zh unknown
- 2007-12-17 AR ARP070105654 patent/AR064379A1/es not_active Application Discontinuation
- 2007-12-19 IN IN3566CHN2009 patent/IN2009CN03566A/en unknown
- 2007-12-19 MX MX2009006889A patent/MX2009006889A/es unknown
- 2007-12-19 CN CN200780047166A patent/CN101848907A/zh active Pending
- 2007-12-19 BR BRPI0721060-4A patent/BRPI0721060A2/pt not_active IP Right Cessation
-
2009
- 2009-05-29 ZA ZA200903779A patent/ZA200903779B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101848907A (zh) | 2010-09-29 |
| TW200843772A (en) | 2008-11-16 |
| AR064379A1 (es) | 2009-04-01 |
| ZA200903779B (en) | 2010-04-28 |
| IN2009CN03566A (https=) | 2015-08-07 |
| BRPI0721060A2 (pt) | 2014-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL198926A0 (en) | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition | |
| UA94660C2 (en) | Amino-heterocyclic compounds | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| CU20110106A7 (es) | Nuevos compuestos 578 | |
| TW200531689A (en) | Therapeutic agents | |
| TW200745135A (en) | Therapeutic agents | |
| ATE455763T1 (de) | Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
| MY155318A (en) | Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists | |
| MX2009003183A (es) | Derivados de sulfonilpirazolincarboxamidina como antagonistas de 5-ht6. | |
| MX2009005509A (es) | 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a). | |
| EP2416795A4 (en) | COGNITIVE DECLINE INHIBITORS | |
| UA100232C2 (uk) | Кристалічні форми інгібітора glyt1 | |
| TW200633957A (en) | Compounds | |
| IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| TW200635589A (en) | Therapeutic agents | |
| GB0428232D0 (en) | Compounds | |
| MX2009006889A (es) | Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa. | |
| WO2008102888A1 (ja) | 新規擬似糖脂質及びその用途 | |
| MX2009007405A (es) | Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina. | |
| MY136718A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
| TW200633956A (en) | Compounds | |
| SI1745010T1 (sl) | Substituirani cikloheksil-1,4-diaminski derivati | |
| TW200714282A (en) | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia | |
| TW200734324A (en) | Therapeutic agents | |
| WO2005095348A3 (en) | Pyrazole-amine compounds for the treatment of neurodegenerative disorders |